Choate Investment Advisors Merck & Co., Inc. Transaction History

Choate Investment Advisors

  • $3.89 Billion
  • Q3 2024

A detailed history of Choate Investment Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Choate Investment Advisors holds 75,525 shares of MRK stock, worth $7.36 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
75,525
Previous 81,305 7.11%
Holding current value
$7.36 Million
Previous $10.1 Million 14.79%
% of portfolio
0.22%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$111.15 - $128.97 $642,447 - $745,446
-5,780 Reduced 7.11%
75,525 $8.58 Million
Q2 2024

Aug 08, 2024
BUY
$123.8 - $132.96 $93,840 - $100,783
758 Added 0.94%
81,305 $10.1 Million
Q1 2024

May 07, 2024
BUY
$113.24 - $131.95 $102,368 - $119,282
904 Added 1.14%
80,547 $10.6 Million
Q4 2023

Feb 14, 2024
BUY
$100.18 - $109.02 $325,885 - $354,642
3,253 Added 4.26%
79,643 $8.68 Million
Q3 2023

Oct 30, 2023
BUY
$102.95 - $114.33 $875,795 - $972,605
8,507 Added 12.53%
76,390 $7.86 Million
Q2 2023

Aug 01, 2023
BUY
$108.61 - $118.38 $1.22 Million - $1.33 Million
11,214 Added 19.79%
67,883 $7.83 Million
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $24,705 - $27,566
-240 Reduced 0.42%
56,669 $6.03 Million
Q4 2022

Feb 14, 2023
BUY
$87.44 - $112.11 $53,950 - $69,171
617 Added 1.1%
56,909 $6.31 Million
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $61,622 - $69,225
-729 Reduced 1.28%
56,292 $4.85 Million
Q2 2022

Aug 11, 2022
BUY
$83.49 - $94.64 $58,693 - $66,531
703 Added 1.25%
57,021 $5.2 Million
Q1 2022

Apr 29, 2022
SELL
$73.51 - $82.4 $60,939 - $68,309
-829 Reduced 1.45%
56,318 $4.62 Million
Q4 2021

Feb 07, 2022
SELL
$72.28 - $90.54 $63,461 - $79,494
-878 Reduced 1.51%
57,147 $4.38 Million
Q3 2021

Nov 04, 2021
SELL
$71.68 - $78.83 $289,802 - $318,709
-4,043 Reduced 6.51%
58,025 $4.36 Million
Q2 2021

Jul 30, 2021
SELL
$70.31 - $77.77 $516,286 - $571,065
-7,343 Reduced 10.58%
62,068 $4.83 Million
Q1 2021

May 07, 2021
BUY
$68.86 - $81.11 $72,647 - $85,571
1,055 Added 1.54%
69,411 $5.35 Million
Q4 2020

Feb 08, 2021
SELL
$71.77 - $79.65 $13,708 - $15,213
-191 Reduced 0.28%
68,356 $5.59 Million
Q3 2020

Oct 26, 2020
SELL
$73.18 - $82.95 $150,604 - $170,711
-2,058 Reduced 2.91%
68,547 $5.69 Million
Q2 2020

Jul 23, 2020
SELL
$70.42 - $80.13 $84,644 - $96,316
-1,202 Reduced 1.67%
70,605 $5.46 Million
Q1 2020

May 07, 2020
SELL
$63.36 - $87.82 $146,044 - $202,425
-2,305 Reduced 3.11%
71,807 $5.53 Million
Q4 2019

Jan 28, 2020
SELL
$77.58 - $87.54 $30,411 - $34,315
-392 Reduced 0.53%
74,112 $6.74 Million
Q3 2019

Nov 13, 2019
SELL
$76.08 - $82.93 $266,280 - $290,255
-3,500 Reduced 4.49%
74,504 $6.27 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $87,160 - $101,824
1,248 Added 1.63%
78,004 $6.54 Million
Q1 2019

Apr 29, 2019
BUY
$69.58 - $79.36 $326,260 - $372,119
4,689 Added 6.51%
76,756 $6.38 Million
Q4 2018

Feb 14, 2019
BUY
$65.24 - $75.71 $7,567 - $8,782
116 Added 0.16%
72,067 $5.51 Million
Q3 2018

Nov 14, 2018
SELL
$57.69 - $67.84 $8,307 - $9,768
-144 Reduced 0.2%
71,951 $5.1 Million
Q2 2018

Jul 30, 2018
BUY
$50.83 - $59.72 $177,295 - $208,303
3,488 Added 5.08%
72,095 $4.38 Million
Q1 2018

May 04, 2018
SELL
$50.96 - $59.23 $14,676 - $17,058
-288 Reduced 0.42%
68,607 $0
Q4 2017

Feb 14, 2018
SELL
$51.62 - $61.64 $82,333 - $98,315
-1,595 Reduced 2.26%
68,895 $0
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $4.14 Million - $4.45 Million
70,490
70,490 $0

Others Institutions Holding MRK

# of Institutions
3,819
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Choate Investment Advisors Portfolio

Follow Choate Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email